$PHG

KONINKLIJKE PHILIPS NV

Philips is a health technology company based in Amsterdam, the Netherlands. Its businesses span diagnosis and treatment, connected care, and personal health. Philips offers diagnostic imaging products such as ultrasound, magnetic resonance imaging, computed tomography and X-ray equipment. It also provides systems and devices for image-guided therapy, along with monitoring, enterprise informatics, sleep and respiratory care, and personal health products.

1
1
0

No SEC Form 4 filings for $PHG in the last 30 days.

See all $PHG insider activity →
Low

Royal Philips: Philips introduces Skylight Device Manager to turn ultrasound data into operational intelligence

Royal Philips (PHG) introduced Skylight Device Manager, a cloud-based app for managing ultrasound system data. It aims to help healthcare organizations optimize operations, staffing, and resource allocation. The solution is available through Philips OneSpace Platform and will be showcased at RSNA 2026. Philips plans to expand it to other imaging modalities.

Philips to nominate Dick Boer, Laurence Debroux and Todd Brinton to its Supervisory Board at the 2027 Annual General Meeting of Shareholders (AGM)

Philips plans to nominate Dick Boer, Laurence Debroux, and Todd Brinton to its Supervisory Board at the 2027 AGM. Boer, former CEO of Ahold Delhaize, will become Vice-Chairman. Debroux, ex-CFO of Heineken, will chair the Audit Committee. Brinton, CSO at Edwards Lifesciences, will join the board. Paul Stoffels, Liz Doherty, and Sanjay Poonen will retire. John DeFord will lead the Quality & Regulatory Committee.

Philips: 3 Key Takeaways for Long-Term Investors

Philips reported an 8% increase in equipment order intake for Q3 2026, driven by health systems prioritizing long-term value over price. The company is shifting to subscription models like EMaaS, which doubled year-over-year revenue. Cost-cutting measures saved EUR 427 million year-to-date, offsetting inflation. Full-year order intake is up 4%, with comparable sales growth at 3.5%.

PHG sentiment & insider activity

Over the past 7 days, AlphAI's AI scored 2 news stories mentioning PHG (KONINKLIJKE PHILIPS NV). Coverage has skewed bullish: 1 bullish, 1 neutral, and 0 bearish.

Recent PHG coverage spans earnings, technology and financial news.

What's driving PHG

AlphAI scores every news story that mentions PHG with an AI model for sentiment and relevance, and aggregates insider trades from KONINKLIJKE PHILIPS NV's SEC EDGAR Form 4 filings. Figures refresh continuously.

News on $PHG

Score

Royal Philips: Philips introduces Skylight Device Manager to turn ultrasound data into operational intelligence

Royal Philips (PHG) introduced Skylight Device Manager, a cloud-based app for managing ultrasound system data. It aims to help healthcare organizations optimize operations, staffing, and resource allocation. The solution is available through Philips OneSpace Platform and will be showcased at RSNA 2026. Philips plans to expand it to other imaging modalities.

Philips to nominate Dick Boer, Laurence Debroux and Todd Brinton to its Supervisory Board at the 2027 Annual General Meeting of Shareholders (AGM)

Philips plans to nominate Dick Boer, Laurence Debroux, and Todd Brinton to its Supervisory Board at the 2027 AGM. Boer, former CEO of Ahold Delhaize, will become Vice-Chairman. Debroux, ex-CFO of Heineken, will chair the Audit Committee. Brinton, CSO at Edwards Lifesciences, will join the board. Paul Stoffels, Liz Doherty, and Sanjay Poonen will retire. John DeFord will lead the Quality & Regulatory Committee.

$PHGMedAI 8/10

Philips: 3 Key Takeaways for Long-Term Investors

Philips reported an 8% increase in equipment order intake for Q3 2026, driven by health systems prioritizing long-term value over price. The company is shifting to subscription models like EMaaS, which doubled year-over-year revenue. Cost-cutting measures saved EUR 427 million year-to-date, offsetting inflation. Full-year order intake is up 4%, with comparable sales growth at 3.5%.

$PHGMedAI 8/10Earnings

KONINKLIJKE PHILIPS NV (PHG): Financial results for Q3 2026

KONINKLIJKE PHILIPS NV (PHG) furnished an SEC Form 6-K — earnings release. Yes ☐ No ☒ Name and address of person authorized to receive notices and communications from the Securities and Exchange Commission: M.J. van Ginneken Koninklijke Philips N.V. Prinses Irenestraat 59 1077 WV Amsterdam – The Netherlands This report comprises a copy of the following

$PHGMedAI 8/10

Philips Q3 adjusted earnings rise as order intake strengthens

Philips reported Q3 adjusted earnings growth, with comparable sales up 3% to €4.39B and adjusted EBITA up to €569M. Net income fell to €28M due to a €288M provision. Sales growth was led by Personal Health and Connected Care. The company reiterated its 2026 outlook, including sales growth of 3-4.5% and adjusted EBITA margin of 13.5-14.0%.

$PHGHighAI 8/10

Ontario picked a Philips system to share over 20 million medical scans a year

Royal Philips reported Q3 2026 sales of EUR 4.4B, up 3%, with an adjusted EBITA margin of 13.0%. The company secured a major contract with Ontario Health for medical scans. Philips also reached an agreement in principle with the US DOJ regarding Respironics recall investigations, recording a EUR 288M provision. The company reiterated its full-year 2026 outlook and announced a EUR 650M green bond issuance.

Doctors can view earlier CT scans beside live images during heart procedures with Philips' tool.

Philips (NYSE: PHG, AEX: PHIA) launched UniGuide 3D Live Guidance in Europe, integrating CT scan data into live heart procedures via its Azurion platform. The tool aims to improve treatment decisions by combining pre-procedural planning with real-time imaging, supporting PCI, structural heart, and vascular procedures. UniGuide is CE-marked and available in select markets from October 23, 2026, but not in the U.S.

Related tickers